1 year return (CAGR)
25.49%
Contineum Therapeutics, Inc. Class A Common Stock Exchange (NASDAQ, USD)
CTNM
14.82
0.00 (0.00%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
488.45M
Price/Sales
-
Ent value
484.44M
Price/Book
2.04
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 14.89 |
| Daily high | 15.51 |
| Daily low | 14.74 |
| Daily Volume | 601K |
| All-time high | 21.75 |
| 1y analyst estimate | 23.43 |
| Beta | 0.74 |
| EPS (TTM) | -1.54 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 5 Mar 2026 |
Downside potential
Loading...
Downside potential data
| CTNM | S&P500 | |
| Current price drop from All-time high | -31.86% | -2.19% |
| Highest price drop | -84.37% | -56.47% |
| Date of highest drop | 28 May 2025 | 9 Mar 2009 |
| Avg drop from high | -40.02% | -10.68% |
| Avg time to new high | 34 days | 12 days |
| Max time to new high | 543 days | 1805 days |
News
